JavaScript is disabled for your browser. Some features of this site may not work without it.
Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis
Dengue hemorrhagic fever (DHF) is a severe condition resulting from the dengue virus, with four serotypes
known as DEN-1, DEN-2, DEN-3, and DEN-4. Genetic variations play a crucial role in influencing susceptibility
to DHF. Therefore, this investigation conducted a meta-analysis to uncover genetic changes that
might have remained undetected in individual studies due to small sample sizes or methodological differences.
Among 2212 initially identified studies, 23 were deemed suitable for analysis based on PRISMA
guidelines. Toll-like receptors (TLR) and CD209 showed significant association with DHF (odds ratios:
TLR=0.56, CD209 =0.55), indicating protective effects. However, tumor necrosis factor (TNF) and human
leukocyte antigen (HLA) did not exhibit a statistically significant relationship with DHF. This study emphasizes
the relevance of TLR and CD209 in DHF susceptibility and resistance across diverse geographical
locations.